•
Mar 31, 2017

Corcept Therapeutics Q1 2017 Earnings Report

Total Revenue
$27.6M
Previous year: $16.1M
+71.8%
EPS
$0.06
Previous year: $0.02
+200.0%
Gross Profit
$27M
Cash and Equivalents
$38M
Total Assets
$75.3M

Corcept Therapeutics

Corcept Therapeutics